Article

Accelerated Cardiac Magnetic Resonance Imaging in the Mouse Using an Eight-Channel Array at 9.4 Tesla

British Heart Foundation Experimental MR Unit (BMRU), Department of Cardiovascular Medicine, University of Oxford, Oxford OX3 7BN, United Kingdom.
Magnetic Resonance in Medicine (Impact Factor: 3.4). 01/2011; 65(1):60-70. DOI: 10.1002/mrm.22605
Source: PubMed

ABSTRACT MRI has become an important tool to noninvasively assess global and regional cardiac function, infarct size, or myocardial blood flow in surgically or genetically modified mouse models of human heart disease. Constraints on scan time due to sensitivity to general anesthesia in hemodynamically compromised mice frequently limit the number of parameters available in one imaging session. Parallel imaging techniques to reduce acquisition times require coil arrays, which are technically challenging to design at ultrahigh magnetic field strengths. This work validates the use of an eight-channel volume phased-array coil for cardiac MRI in mice at 9.4 T. Two- and three-dimensional sequences were combined with parallel imaging techniques and used to quantify global cardiac function, T(1)-relaxation times and infarct sizes. Furthermore, the rapid acquisition of functional cine-data allowed for the first time in mice measurement of left-ventricular peak filling and ejection rates under intravenous infusion of dobutamine. The results demonstrate that a threefold accelerated data acquisition is generally feasible without compromising the accuracy of the results. This strategy may eventually pave the way for routine, multiparametric phenotyping of mouse hearts in vivo within one imaging session of tolerable duration.

Full-text

Available from: Jurgen E Schneider, May 30, 2015
0 Followers
 · 
214 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The use of MR imaging and spectroscopy for studying cardiovascular disease processes in small animals has increased tremendously over the past decade. This is the result of the remarkable advances in MR technologies and the increased availability of genetically modified mice. MR techniques provide a window on the entire timeline of cardiovascular disease development, ranging from subtle early changes in myocardial metabolism that often mark disease onset to severe myocardial dysfunction associated with end-stage heart failure. MR imaging and spectroscopy techniques play an important role in basic cardiovascular research and in cardiovascular disease diagnosis and therapy follow-up. This is due to the broad range of functional, structural and metabolic parameters that can be quantified by MR under in vivo conditions non-invasively. This review describes the spectrum of MR techniques that are employed in small animal cardiovascular disease research and how the technological challenges resulting from the small dimensions of heart and blood vessels as well as high heart and respiratory rates, particularly in mice, are tackled.
    Progress in Nuclear Magnetic Resonance Spectroscopy 08/2015; 88. DOI:10.1016/j.pnmrs.2015.03.001 · 8.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fallzahlen chronischer Nierenerkrankungen (CKD) steigen weltweit. In Europa sind z.B. mindestens 8% der Bevölkerung betroffen. CKD ist der Ausgangpunkt für eine reduzierte Lebenserwartung und einer hohen Komorbidität, welches sozio-ökonomischen Kosten nach sich zieht. Daher sind eine frühe Erkennung und eine adäquate Therapie von Nierenerkrankungen wichtig. Präklinische Forschung kann dabei helfen, die Grundmechanismen dieser Krankheitsbilder zu verstehen, aber auch neue Medikamente für eine mögliche Therapie zu testen. Funktionale Magnetresonanztomographie (MRT) bietet dabei die Möglichkeit nicht-invasiv Zugang zu Gewebe- und Organfunktion zu erhalten. Vorteil gegenüber klassischen Tierversuchen ist, dass die Tiere hierbei nicht getötet werden müssen und mehrmals untersucht werden können, z.B. in Verlaufsuntersuchungen. Neben dem wissenschaftlichen Gewinn trägt dies auch direkt zum Tierschutz bei, da mit MRT-Techniken klassische Tierversuche überarbeitet werden können und so Tierzahlen reduziert werden können. In diesem Beitrag stellen wir den aktuellen Stand der präklinischen funktionalen MRT mit einem Fokus auf Nierenbildgebung vor.
    Zeitschrift für Medizinische Physik 12/2014; DOI:10.1016/j.zemedi.2014.06.008 · 1.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: PurposeGene-modified mice may be used to elucidate molecular mechanisms underlying abnormal myocardial blow flow (MBF). We sought to develop a quantitative myocardial perfusion imaging technique for mice and to test the hypothesis that myocardial perfusion reserve (MPR) is reduced in a mouse model of diet-induced obesity (DIO).MethodsA dual-contrast saturation-recovery sequence with ky-t undersampling and a motion-compensated compressed sensing reconstruction algorithm was developed for first-pass MRI on a small-bore 7 Tesla system. Control mice were imaged at rest and with the vasodilators ATL313 and Regadenoson (n = 6 each). In addition, we imaged mice fed a high-fat diet (HFD) for 24 weeks.ResultsIn control mice, MBF was 5.7 ± 0.8 mL/g/min at rest and it increased to 11.8 ± 0.6 mL/g/min with ATL313 and to 10.4 ± 0.3 mL/g/min with Regadenoson. In HFD mice, we detected normal resting MBF (5.6 ± 0.4 versus 5.0 ± 0.3 on control diet), low MBF at stress (7.7 ± 0.4 versus 10.4 ± 0.3 on control diet, P < 0.05), and reduced MPR (1.4 ± 0.2 versus 2.0 ± 0.3 on control diet, P < 0.05).Conclusion Accelerated dual-contrast first-pass MRI with motion-compensated compressed sensing provides spatiotemporal resolution suitable for measuring MBF in free-breathing mice, and detected reduced MPR in DIO mice. These techniques may be used to study molecular mechanisms that underlie abnormal myocardial perfusion. Magn Reson Med, 2014. © 2014 Wiley Periodicals, Inc.
    Magnetic Resonance in Medicine 04/2014; 73(3). DOI:10.1002/mrm.25238 · 3.40 Impact Factor